Cargando…

IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway

OBJECTIVE: The dysfunction of immune surveillance, a hot spot in cancer research, could lead to the occurrence and development in multicancers. However, the potential mechanisms of immunity in Wilms' tumor (WT) remain unclear on Wilms' tumor (WT). In this study, we aim to investigate the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yanping, Li, Yonglin, Xiang, Bin, Tian, Xiaomao, Shi, Qinlin, Liu, Feng, Lin, Tao, Wei, Guanghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546681/
https://www.ncbi.nlm.nih.gov/pubmed/36213822
http://dx.doi.org/10.1155/2022/4544773
_version_ 1784805097156378624
author Li, Yanping
Li, Yonglin
Xiang, Bin
Tian, Xiaomao
Shi, Qinlin
Liu, Feng
Lin, Tao
Wei, Guanghui
author_facet Li, Yanping
Li, Yonglin
Xiang, Bin
Tian, Xiaomao
Shi, Qinlin
Liu, Feng
Lin, Tao
Wei, Guanghui
author_sort Li, Yanping
collection PubMed
description OBJECTIVE: The dysfunction of immune surveillance, a hot spot in cancer research, could lead to the occurrence and development in multicancers. However, the potential mechanisms of immunity in Wilms' tumor (WT) remain unclear on Wilms' tumor (WT). In this study, we aim to investigate the immune cell in WT and explore the underlying treatment strategy. METHOD: We quantified stromal and immune scores by using ESTIMATE algorithm based on gene expression matrix of WT patients in TCGA and GEO databases. Different expression genes (DEGs) and functional enrichments were analyzed by R studio and DAVID tools. Flow cytometry, immunofluorescence staining, ELISA assay, and qRT-PCR were used for detecting the NK cells, cytotoxic cytokines (INF-γ, PRF, and GZMB), and NK cell receptor expression, respectively. WT patient autologous NK cells were stimulated by IL-2 and IL-15, and the cytotoxicity of NK cells against WT cell lines was detected by LDH assay. Western blot experiment was used for measuring the MAPK signaling pathway protein maker in NK cells. RESULTS: ESTIMATE indicated that WT tissue had a lower immune score than adjacent kidney tissue. Meanwhile, the low immune score group was associated with poorly outcomes. DEG functional enrichment analysis showed that NK cell-mediated cytotoxicity was significantly different in low and high immune score groups. Although few of proportion of NK cells in WT patients were increased, most of that were significantly lower than normal children. Moreover, the proportion of NK cells and the expression level of INF-γ, PRF, and GZMB in WT tissue were lower than adjacent kidney tissue. Importantly, the NKG2D expression level of NK cells was significantly lower in WT tissue. Furthermore, in vitro, compared with uncultured NK cells, IL-2 and IL-15 could effectively enhance the cytotoxicity of NK cells on killing the WT cell lines. The FACS and WB results showed that the NKG2D and p-PI3K ratio PI3K, MEK1/2, and p-ERK1/2 ratio ERK1/2 were significantly increased in IL-2 and IL15 group compared with uncultured groups. CONCLUSION: The abnormal NK cell-mediated cytotoxicity may cause the occurrence of WT. Costimulation of WT patients autologous NK cells could effectively enhance the antitumor reaction which involved in activation of NKG2D-mediated MAPK signaling pathway.
format Online
Article
Text
id pubmed-9546681
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-95466812022-10-08 IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway Li, Yanping Li, Yonglin Xiang, Bin Tian, Xiaomao Shi, Qinlin Liu, Feng Lin, Tao Wei, Guanghui J Oncol Research Article OBJECTIVE: The dysfunction of immune surveillance, a hot spot in cancer research, could lead to the occurrence and development in multicancers. However, the potential mechanisms of immunity in Wilms' tumor (WT) remain unclear on Wilms' tumor (WT). In this study, we aim to investigate the immune cell in WT and explore the underlying treatment strategy. METHOD: We quantified stromal and immune scores by using ESTIMATE algorithm based on gene expression matrix of WT patients in TCGA and GEO databases. Different expression genes (DEGs) and functional enrichments were analyzed by R studio and DAVID tools. Flow cytometry, immunofluorescence staining, ELISA assay, and qRT-PCR were used for detecting the NK cells, cytotoxic cytokines (INF-γ, PRF, and GZMB), and NK cell receptor expression, respectively. WT patient autologous NK cells were stimulated by IL-2 and IL-15, and the cytotoxicity of NK cells against WT cell lines was detected by LDH assay. Western blot experiment was used for measuring the MAPK signaling pathway protein maker in NK cells. RESULTS: ESTIMATE indicated that WT tissue had a lower immune score than adjacent kidney tissue. Meanwhile, the low immune score group was associated with poorly outcomes. DEG functional enrichment analysis showed that NK cell-mediated cytotoxicity was significantly different in low and high immune score groups. Although few of proportion of NK cells in WT patients were increased, most of that were significantly lower than normal children. Moreover, the proportion of NK cells and the expression level of INF-γ, PRF, and GZMB in WT tissue were lower than adjacent kidney tissue. Importantly, the NKG2D expression level of NK cells was significantly lower in WT tissue. Furthermore, in vitro, compared with uncultured NK cells, IL-2 and IL-15 could effectively enhance the cytotoxicity of NK cells on killing the WT cell lines. The FACS and WB results showed that the NKG2D and p-PI3K ratio PI3K, MEK1/2, and p-ERK1/2 ratio ERK1/2 were significantly increased in IL-2 and IL15 group compared with uncultured groups. CONCLUSION: The abnormal NK cell-mediated cytotoxicity may cause the occurrence of WT. Costimulation of WT patients autologous NK cells could effectively enhance the antitumor reaction which involved in activation of NKG2D-mediated MAPK signaling pathway. Hindawi 2022-09-30 /pmc/articles/PMC9546681/ /pubmed/36213822 http://dx.doi.org/10.1155/2022/4544773 Text en Copyright © 2022 Yanping Li et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Li, Yanping
Li, Yonglin
Xiang, Bin
Tian, Xiaomao
Shi, Qinlin
Liu, Feng
Lin, Tao
Wei, Guanghui
IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway
title IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway
title_full IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway
title_fullStr IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway
title_full_unstemmed IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway
title_short IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway
title_sort il-2 combined with il-15 enhanced the expression of nkg2d receptor on patient autologous nk cells to inhibit wilms' tumor via mapk signaling pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546681/
https://www.ncbi.nlm.nih.gov/pubmed/36213822
http://dx.doi.org/10.1155/2022/4544773
work_keys_str_mv AT liyanping il2combinedwithil15enhancedtheexpressionofnkg2dreceptoronpatientautologousnkcellstoinhibitwilmstumorviamapksignalingpathway
AT liyonglin il2combinedwithil15enhancedtheexpressionofnkg2dreceptoronpatientautologousnkcellstoinhibitwilmstumorviamapksignalingpathway
AT xiangbin il2combinedwithil15enhancedtheexpressionofnkg2dreceptoronpatientautologousnkcellstoinhibitwilmstumorviamapksignalingpathway
AT tianxiaomao il2combinedwithil15enhancedtheexpressionofnkg2dreceptoronpatientautologousnkcellstoinhibitwilmstumorviamapksignalingpathway
AT shiqinlin il2combinedwithil15enhancedtheexpressionofnkg2dreceptoronpatientautologousnkcellstoinhibitwilmstumorviamapksignalingpathway
AT liufeng il2combinedwithil15enhancedtheexpressionofnkg2dreceptoronpatientautologousnkcellstoinhibitwilmstumorviamapksignalingpathway
AT lintao il2combinedwithil15enhancedtheexpressionofnkg2dreceptoronpatientautologousnkcellstoinhibitwilmstumorviamapksignalingpathway
AT weiguanghui il2combinedwithil15enhancedtheexpressionofnkg2dreceptoronpatientautologousnkcellstoinhibitwilmstumorviamapksignalingpathway